Stocks to Watch Wednesday: Netflix, QXO, Moderna, SLB -- WSJ

Dow Jones
Yesterday

By WSJ Staff

Warner Bros. Discovery $(WBD)$: Activist investor Ancora has built a roughly $200 million stake in Warner and plans to oppose its deal with Netflix $(NFLX)$. Ancora thinks Warner failed to adequately engage with Paramount Skydance $(PSKY)$'s rival offer.

Halliburton $(HAL)$ and SLB $(SLB)$: The Trump administration issued a general license that allows U.S. oilfield-services providers to work in Venezuela. Both stocks rose at least 2.5%.

Moderna (MRNA): The U.S. Food and Drug Administration refused to review the drugmaker's application to sell a new seasonal flu vaccine. Shares slid 11%.

QXO $(QXO)$: The building-materials company agreed to buy closely held Kodiak Building Partners for about $2.25 billion. QXO said the deal would boost 2026 earnings. Shares jumped 11%.

London Stock Exchange Group (UK:LSEG): Activist investor Elliott Investment Management has taken a stake in the financial-data provider and exchange operator. Shares in the LSE slipped.

AST SpaceMobile $(ASTS)$: The company, which is building a broadband cellular network in space, said the next-generation BlueBird 6 satellite had successfully unfolded. Shares gained 3%.

This item is part of a Wall Street Journal live coverage event. The full stream can be found by searching P/WSJL (WSJ Live Coverage).

(END) Dow Jones Newswires

February 11, 2026 10:00 ET (15:00 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10